Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy.
Martínez-Castedo B, Camblor DG, Martín-Arana J, Carbonell-Asins JA, García-Micó B, Gambardella V, Huerta M, Roselló S, Roda D, Gimeno-Valiente F, Cervantes A, Tarazona N.
Martínez-Castedo B, et al. Among authors: cervantes a.
Ann Oncol. 2024 Dec 13:S0923-7534(24)04981-0. doi: 10.1016/j.annonc.2024.12.006. Online ahead of print.
Ann Oncol. 2024.
PMID: 39675560
Review.